Table 2. Numbers of 2000–2009 Approvals for G-Finder Defined Neglected Diseases.
| Disease Category | Our Analysis | |
| Drugs/Vaccines | Indications | |
| HIV/AIDS* | 10 | 10 |
| Malaria | 11 | 11 |
| Tuberculosis | 0 | 0 |
| Bacterial Pneumonia and Meningitis | 1 | 1 |
| Diarrheal Diseases | 3 | 3 |
| Kinetoplastids | 1 | 1 |
| Buruli Ulcer | 0 | 0 |
| Dengue Fever | 0 | 0 |
| Helminths | 0 | 0 |
| Leprosy | 0 | 0 |
| Trachoma | 0 | 0 |
| Rheumatic Fever | 0 | 0 |
| Typhoid and Paratyphoid Fever | 0 | 0 |
| Total Approvals | 26 | 26 |
| Percentage on Essential Drug List | 50% | 50% |
*HIV/AIDS drugs with applications specific to the developing world, such as vaccines, microbicides and pediatric label extensions. Sources: PharmaProjects, IMS R&D Focus, http://www.accessdata.fda.gov/Scripts/cder/DrugsatFDA, http://eudrapharm.eu/eudrapharm/searchbykeyword.do, http://www.cbg-meb.nl/CBG/en/human-medicines/actueel, http://www.pharmacyboardkenya.org/index.php?id=13&dpgndg1=42&an=, http://www.who.int/medicines/publications/08_ENGLISH_indexFINAL_EML15.pdf, http://www.cdsco.nic.in/, http://www.afssaps.fr/, http://www.mhra.gov.uk/index.htm, http://www.bmg.bund.de.